|
Market Closed -
Other stock markets
|
Pre-market 08:47:50 am | |||
| 19.55 USD | +0.77% |
|
19.56 | +0.08% |
| Capitalization | 3.91B 3.36B 3.15B 2.94B 5.42B 352B 5.9B 36.84B 14.23B 166B 14.68B 14.37B 608B | P/E ratio 2025 * |
-181x | P/E ratio 2026 * | 215x |
|---|---|---|---|---|---|
| Enterprise value | 3.65B 3.14B 2.94B 2.74B 5.06B 328B 5.5B 34.37B 13.27B 155B 13.7B 13.4B 567B | EV / Sales 2025 * |
0.93x | EV / Sales 2026 * | 0.71x |
| Free-Float |
55.92% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Alignment Healthcare, Inc.
| 1 day | +0.77% | ||
| 1 week | +1.77% | ||
| Current month | +1.77% | ||
| 1 month | +19.72% | ||
| 3 months | +23.27% | ||
| 6 months | +28.45% | ||
| Current year | +73.78% |
| 1 week | 18.82 |  | 19.99 |
| 1 month | 15.84 | | 19.99 |
| Current year | 11.3 | | 21.06 |
| 1 year | 10.18 | | 21.06 |
| 3 years | 4.46 | | 21.06 |
| 5 years | 4.46 | | 28.59 |
| 10 years | 4.46 | | 28.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Kao
CEO | Chief Executive Officer | 63 | 2013-12-31 |
James Head
DFI | Director of Finance/CFO | 60 | 2025-05-01 |
Dawn Maroney
PSD | President | 57 | 2025-01-12 |
| Director | Title | Age | Since |
|---|---|---|---|
John Kao
BRD | Director/Board Member | 63 | 2013-12-31 |
David Hodgson
BRD | Director/Board Member | 68 | 2013-12-31 |
Mark McClellan
BRD | Director/Board Member | 61 | 2013-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.03% | 324 M€ | +10.62% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.77% | +1.77% | +71.64% | +62.11% | 3.91B | |
| -0.77% | +0.35% | -39.79% | -39.05% | 300B | |
| -0.82% | -2.22% | -13.45% | -37.58% | 73.51B | |
| -1.11% | -4.27% | -16.48% | -20.09% | 70.91B | |
| +1.91% | +4.92% | -8.48% | -53.05% | 31.01B | |
| -1.31% | -2.54% | -32.45% | -56.11% | 18.84B | |
| +0.86% | +2.43% | -48.52% | -55.24% | 7.81B | |
| -0.54% | -8.91% | +62.74% | -25.54% | 2.07B | |
| -3.01% | +3.61% | -23.21% | +116.81% | 1.33B | |
| -0.17% | -1.03% | -21.87% | - | 388M | |
| Average | -0.24% | -0.70% | -6.99% | -11.97% | 50.95B | |
| Weighted average by Cap. | -0.38% | -0.48% | -29.37% | -36.69% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.94B 3.38B 3.17B 2.95B 5.46B 354B 5.94B 37.07B 14.31B 167B 14.77B 14.46B 612B | 5.09B 4.38B 4.1B 3.82B 7.06B 458B 7.68B 47.95B 18.52B 216B 19.11B 18.7B 791B |
| Net income | -24.6M -21.15M -19.81M -18.47M -34.11M -2.21B -37.1M -232M -89.48M -1.05B -92.34M -90.37M -3.82B | 20.14M 17.31M 16.22M 15.12M 27.92M 1.81B 30.37M 190M 73.25M 856M 75.6M 73.99M 3.13B |
| Net Debt | -263M -226M -212M -197M -364M -23.64B -396M -2.47B -955M -11.17B -986M -965M -40.83B | -302M -260M -244M -227M -419M -27.21B -456M -2.85B -1.1B -12.85B -1.13B -1.11B -47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 19.55 $ | +0.77% | 1,694,271 |
| 25-12-04 | 19.40 $ | +1.57% | 2,882,276 |
| 25-12-03 | 19.10 $ | +0.05% | 1,857,466 |
| 25-12-02 | 19.09 $ | +0.05% | 2,674,933 |
| 25-12-01 | 19.08 $ | -0.68% | 3,051,221 |
Delayed Quote Nasdaq, December 05, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALHC Stock
Select your edition
All financial news and data tailored to specific country editions
